Killer50 Profiles
-
Adrestia Therapeutics
Adrestia Therapeutics secured undisclosed Series A investment from GSK in 2020 to progress technology designed to restore diseased cells by... Read More
-
Quantinuum
The world’s largest integrated quantum computing company – Quantinuum – was recently rolled out by Honeywell Quantum Solutions and Cambridge Quantum... Read More
-
Qureight
Qureight is a Cambridge company which uses cloud-based technology to assist in the structuring of image and paired clinical metadata in complex... Read More
-
Porotech
Porotech is a spin-out from the Cambridge Centre for Gallium Nitride in the Department of Materials Science and Metallurgy at the University of... Read More
-
Nu Quantum
Nu Quantum is creating high-performance, single-photon technologies that will predicate the future of quantum information processing. The scalable... Read More
-
IQGeo
IQGeo delivers award-winning geospatial software solutions to telecoms and utility network operators from large multinationals to small regional... Read More
-
Eliem Therapeutics
Eliem Therapeutics is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address... Read More
-
Cambridge GaN Devices
Cambridge GaN Devices (CGD) was created to explore and develop a number of unique opportunities in power electronics made possible by the team’s... Read More
-
Apollo Therapeutics
In 2021, portfolio-based biopharma venture Apollo Therapeutics announced it was expanding its Cambridge UK and Boston US operations after... Read More
-
PetMedix
PetMedix is applying 30 years of antibody research and the scientific work of two of its founders, Professor Allan Bradley and Dr Jolyon Martin, to... Read More
-
SATAVIA
SATAVIA has developed a patented software platform to make aviation smarter, and enablie customers to increase cost base efficiency and drive up... Read More
-
Alchemab Therapeutics
Alchemab has developed a highly differentiated platform which enables the identification of novel drug targets and therapeutics by analysis of... Read More
-
Sosei Heptares
Sosei Heptares is an international biopharmaceutical group focused on the design and development of new medicines originating from its proprietary... Read More
-
Mogrify
Mogrify launched in February 2019 with $3.7m seed funding from Ahren Innovation Capital, 24Haymarket and CEO Darrin Disley and went on to secure... Read More
-
Microbiotica
Microbiotica was only founded in 2016 but is already collaring a European lead in microbiome technology. It is researching the body’s... Read More
-
Artios Pharma
Artios Pharma, a leading DNA Damage Response company developing innovative treatments for cancer, completed an $84 million Series B financing in... Read More
-
PhoreMost
PhoreMost has grown from a Cambridge University spin-out in 2015 with early proof-of-concept data, to a technically and commercially validated... Read More
-
Astex Pharmaceuticals
A global biotech company focused on the discovery and development of drugs in oncology and other areas. Astex Pharmaceuticals, Inc. was... Read More
-
Johnson Matthey
Johnson Matthey is a British multinational speciality chemicals and sustainable technologies company with major operations in Cambridge and Royston.... Read More
-
bit.bio
bit.bio specialises in creating ready-to-culture mature human cells for research which are used as models in science, drug discovery and toxicology.... Read More